IL-9 Antibody, anti-mouse, REAfinity™
Synonyms: P40
RECOMBINANT
Clone:
REA1035 | RM9A4
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for IL-9 Antibody, anti-mouse, REAfinity™

Intracellular flow cytometry applications
APC
PE
Vio R667
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-117-575
Description:
CD4+/ CD62+ T cells were enriched with the CD4+/ CD62L+ T Cell Isolation Kit II, mouse from splenocytes of BALB/c mice. Cells were stimulated with plate-bound CD3 and soluble CD28 antibodies in the presence recombinant IL-4, IL-2, TGFß-1 and neutralizing Anti-IL-6 antibodies, Anti- IFN-γ antibodies and Anti-IL-12 antibodies for 5 days. Cells were harvested, fixed, permeabilized, and intracellularly stained with Anti-IL-9 antibodies or with the REA Control antibodies (left image), as well as with CD4 antibodies. Cells were analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Specifications for IL-9 Antibody, anti-mouse, REAfinity™
Overview

Interleukin-9 (IL-9) is secreted by mast cells and T helper (Tʜ) cells. First IL-9 production was associated to Tʜ2 cells, but it was also found in other Tʜ subsets. Recently, evidence for the existence of a specialized lineage of Tʜ cells producing IL-9, named Tʜ9, came up. IL-9 has pleiotropic effects, e.g., it promotes mast cell growth and function, is involved in CD4+ T cell subset differentiation and growth, enhances IgE production, supports hematopoiesis, and acts on airway and gut epithelial cells.

Additional information: Clone REA1035 displays negligible binding to Fc receptors.

Alternative names

P40

Detailed product information

Technical specifications

Clone
REA1035
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
IL-9
Molecular mass of antigen [kDa]
14
Distribution of antigen
mast cells, T helper cells, Th2 cells
Entrez Gene ID
RRID
AB_2751402, AB_2751389, AB_2751401, AB_2751388, AB_2751400

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for IL-9 Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?